These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 25850463

  • 1. Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial.
    Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, Marrs T, Hanna H, Phillips K, Pinto C, Turner PJ, Warner JO, Boyle RJ.
    Allergy; 2015 Jul; 70(7):855-63. PubMed ID: 25850463
    [Abstract] [Full Text] [Related]

  • 2. Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey.
    Portnoy J, Wade RL, Kessler C.
    J Allergy Clin Immunol Pract; 2019 Jul; 7(7):2252-2261. PubMed ID: 30922991
    [Abstract] [Full Text] [Related]

  • 3. Auvi-Q versus EpiPen: preferences of adults, caregivers, and children.
    Camargo CA, Guana A, Wang S, Simons FE.
    J Allergy Clin Immunol Pract; 2013 Jul; 1(3):266-72.e1-3. PubMed ID: 24565484
    [Abstract] [Full Text] [Related]

  • 4. Comparison of adrenaline auto-injector devices: ease of use and ability to recall use.
    Robinson MN, Dharmage SC, Tang ML.
    Pediatr Allergy Immunol; 2014 Aug; 25(5):462-7. PubMed ID: 25041111
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.
    Salter SM, Loh R, Sanfilippo FM, Clifford RM.
    Allergy Asthma Clin Immunol; 2014 Aug; 10(1):49. PubMed ID: 25264449
    [Abstract] [Full Text] [Related]

  • 6. A randomized maternal evaluation of epinephrine autoinjection devices.
    Brown J, Tuthill D, Alfaham M, Spear E.
    Pediatr Allergy Immunol; 2013 Mar; 24(2):173-7. PubMed ID: 23448513
    [Abstract] [Full Text] [Related]

  • 7. Patterns of Carriage of Prescribed Adrenaline Autoinjectors in 10- to 14-Year-Old Food-Allergic Students: A Population-Based Study.
    Robinson M, Koplin JJ, Field MJ, Sasaki M, Peters RL, McWilliam V, Sawyer SM, Patton GC, Vuillermin PJ, Douglass J, Gurrin LC, Tang MLK, Dharmage SC, Allen KJ, SchoolNuts Investigators.
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):437-443. PubMed ID: 30031901
    [Abstract] [Full Text] [Related]

  • 8. Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen Jr.
    Kessler C, Edwards E, Dissinger E, Sye S, Visich T, Grant E.
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):256-262. PubMed ID: 31228629
    [Abstract] [Full Text] [Related]

  • 9. Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study.
    Patel N, Isaacs E, Duca B, Nagaratnam N, Donovan J, Fontanella S, Turner PJ.
    Allergy; 2023 Jul; 78(7):1997-2006. PubMed ID: 36794963
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability of epinephrine from Auvi-Q compared with EpiPen.
    Edwards ES, Gunn R, Simons ER, Carr K, Chinchilli VM, Painter G, Goldwater R.
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):132-7. PubMed ID: 23886232
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the robustness and functionality of three adrenaline auto-injectors.
    Schwirtz A, Seeger H.
    J Asthma Allergy; 2012 Aug; 5():39-49. PubMed ID: 22952410
    [Abstract] [Full Text] [Related]

  • 12. Physicians prescribe adrenaline autoinjectors, do parents use them when needed?
    Esenboga S, Ocak M, Cetinkaya PG, Sahiner UM, Soyer O, Buyuktiryaki B, Sekerel BE.
    Allergol Immunopathol (Madr); 2020 Aug; 48(1):3-7. PubMed ID: 31611040
    [Abstract] [Full Text] [Related]

  • 13. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference.
    Guerlain S, Hugine A, Wang L.
    Ann Allergy Asthma Immunol; 2010 Feb; 104(2):172-7. PubMed ID: 20306821
    [Abstract] [Full Text] [Related]

  • 14. Parental knowledge and use of epinephrine auto-injector for children with food allergy.
    Pouessel G, Deschildre A, Castelain C, Sardet A, Sagot-Bevenot S, de Sauve-Boeuf A, Thumerelle C, Santos C.
    Pediatr Allergy Immunol; 2006 May; 17(3):221-6. PubMed ID: 16672011
    [Abstract] [Full Text] [Related]

  • 15. Pharmacists' response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice.
    Salter SM, Delfante B, de Klerk S, Sanfilippo FM, Clifford RM.
    BMJ Open; 2014 Jul 09; 4(7):e005648. PubMed ID: 25009138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Status of children with food allergy who were prescribed an adrenaline autoinjector (epipen)].
    Mukaida K, Kusunoki T, Nozaki F, Hiejima I, Hayashi A, Kumada T, Miyajima T, Fujii T.
    Arerugi; 2014 May 09; 63(5):686-94. PubMed ID: 24865961
    [Abstract] [Full Text] [Related]

  • 18. Trends in adrenaline (EpiPen) dispensing in Israel in 1997-2004.
    Levy Y, Segal N, Danon YL.
    Public Health; 2007 Feb 09; 121(2):144-7. PubMed ID: 17161854
    [Abstract] [Full Text] [Related]

  • 19. Repeated freezing to very low temperatures does not impact the amount ejected from EpiPen® and Jext® adrenaline autoinjectors.
    Wood FNR, Hartley R, Boys R, Parham T, Lowe J, Warner M.
    Int J Circumpolar Health; 2024 Dec 09; 83(1):2367273. PubMed ID: 38875453
    [Abstract] [Full Text] [Related]

  • 20. A real-life study on acquired skills from using an adrenaline autoinjector.
    Topal E, Bakirtas A, Yilmaz O, Ertoy IH, Arga M, Demirsoy MS, Turktas I.
    Int Arch Allergy Immunol; 2013 Dec 09; 160(3):301-6. PubMed ID: 23095342
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.